FibroGen, Inc. (FGEN)

FibroGen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	131	113.69	155.7	171.22	678.39	126.27
Short-Term Investments	-	121.9	266.31	233.97	8.14	407.49
Cash & Short-Term Investments	131	235.59	422.01	405.19	686.54	533.76
Cash Growth	-47.88%	-44.17%	4.15%	-40.98%	28.62%	-14.10%
Accounts Receivable	54.83	12.55	16.3	25.4	41.88	153.67
Other Receivables	28.5	28.5	-	-	-	-
Receivables	83.33	41.05	16.3	25.4	41.88	153.67
Inventory	23.94	41.57	40.44	31.02	16.53	6.89
Prepaid Expenses	3.06	6.64	9.73	7.38	8.35	6.46
Other Current Assets	3.19	6.71	4.35	5.07	1.81	1.72
Total Current Assets	244.53	331.56	492.83	474.06	755.11	702.49
Property, Plant & Equipment	9.7	81.37	100.93	120.15	65.3	84.28
Long-Term Investments	5.81	5.29	9.41	171.62	2.97	61.12
Other Long-Term Assets	4.39	5.31	6.92	7.99	3.46	9.51
Total Assets	264.42	423.53	610.09	773.82	826.84	857.4
Accounts Payable	9.24	17.96	30.76	26.1	24.79	6.09
Accrued Expenses	86.59	71.96	130.19	121.62	89.29	42.95
Current Portion of Leases	1.29	14.12	10.33	10.96	13.52	13.33
Current Unearned Revenue	29.19	18.39	12.74	19.03	21.68	0.49
Other Current Liabilities	64.22	95.24	89.55	47.79	13.91	39.88
Total Current Liabilities	190.53	217.67	273.56	225.5	163.19	102.75
Long-Term Debt	90.98	89.7	16.92	17.61	18.7	16.78
Long-Term Leases	0.71	66.64	79.73	88.78	26.24	40.1
Long-Term Unearned Revenue	183.07	208.97	235.06	186.8	138.47	99.45
Other Long-Term Liabilities	0.84	2.75	6.3	26.02	38.79	62.92
Total Liabilities	466.12	585.73	611.57	544.71	385.39	321.99
Common Stock	1.01	0.99	0.94	0.93	0.91	0.88
Additional Paid-In Capital	1,668	1,644	1,541	1,476	1,400	1,301
Retained Earnings	-1,907	-1,842	-1,558	-1,264	-974.01	-784.72
Comprehensive Income & Other	-5.63	-6.88	-5.72	-4.16	-4.5	-0.75
Total Common Equity	-243.67	-204.17	-21.45	209.15	422.18	516.14
Minority Interest	41.97	41.97	19.97	19.97	19.27	19.27
Shareholders' Equity	-201.7	-162.2	-1.48	229.11	441.45	535.41
Total Liabilities & Equity	264.42	423.53	610.09	773.82	826.84	857.4
Total Debt	92.98	170.46	106.98	117.35	58.46	70.21
Net Cash (Debt)	38.03	65.13	315.03	287.84	628.08	463.55
Net Cash Growth	-52.95%	-79.33%	9.45%	-54.17%	35.49%	-8.48%
Net Cash Per Share	0.38	0.67	3.37	3.12	6.99	5.35
Filing Date Shares Outstanding	100.77	98.77	94.18	93	91.56	88
Total Common Shares Outstanding	100.77	98.77	94.17	92.88	91.44	87.66
Working Capital	54	113.89	219.26	248.56	591.92	599.75
Book Value Per Share	-2.42	-2.07	-0.23	2.25	4.62	5.89
Tangible Book Value	-243.67	-204.17	-21.45	209.15	422.18	516.14
Tangible Book Value Per Share	-2.42	-2.07	-0.23	2.25	4.62	5.89
Machinery	-	47.89	46.5	43.51	42.13	39.77
Construction In Progress	-	0.06	0.2	2.42	0.76	1.79
Leasehold Improvements	-	102.11	102.58	103.35	102.01	101.55

Source: S&P Capital IQ. Standard template. Financial Sources.